Read More

Micron’s Strategic Moves in China, CEO Mehrotra’s Talks and Expansion Plans Amid Shift from US Tech

CEO of Micron Technology, Inc met with China's Minister of Commerce to discuss future development. China supports Micron's investments and plans to cater to Chinese consumers. Recent reports show China's effort to replace US technology with domestic alternatives.

AMD

Read More

Analysts Eye Summit Therapeutics’ Ivonescimab As Potential Challenger To Merck’s Keytruda in Lung Cancer Treatment

Stifel covers Summit Therapeutics, highlighting ivonescimab's promise in phase 3 lung cancer trials, potential market expansion worth billions, and a buy rating with $8 target. Updates from Akeso in 2024 and a $5 billion deal add to the optimism, signaling potential share price growth ahead.

MRK